Literature DB >> 9470875

Florid psychopathology in patients receiving shocks from implanted cardioverter-defibrillators.

J P Bourke1, D Turkington, G Thomas, J M McComb, M Tynan.   

Abstract

OBJECTIVES: To increase awareness of the potential for disabling anxiety and depression in patients receiving shocks from implanted cardioverter-defibrillators (ICDs). PATIENTS AND METHODS: ICDs are implanted in patients at this hospital for control of serious ventricular tachyarrhythmias inadequately controlled by drug treatment, who are unsuitable for map guided antiarrhythmic surgery. All are reviewed regularly at a dedicated ICD clinic and are advised to make contact between visits if they experience shocks. Symptoms of anxiety or depression were not actively sought, nor was a patient support group operating at the time of this data collection. When overt psychopathology was identified, patients were referred to a designated psychiatrist for management.
RESULTS: Over a six year period, six (17%) of 35 patients with ICDs developed florid psychiatric problems after experiencing shocks. None had premorbid psychiatric predisposition. Of the six patients suffering severe psychiatric problems, four were men, their age range was 30-63 years, and left ventricular ejection fraction was 18-40%. All shocks were appropriate for clinical arrhythmias and ranged in frequency from two in six months to 111 in 24 hours. All six patients manifested severe anxiety, focused on fear of future shocks. Depression was also evident in three patients and two had become housebound. All responded within weeks to anxiolytic or antidepressant drugs, combined with relaxation and cognitive therapies. Ongoing psychiatric therapy was refused by one patient, and was required for between three and 18 months in the remainder. One patient died and one received a cardiac transplant during the follow up period (median 27.5 months, range 8-43).
CONCLUSIONS: Because ICD implantation occurs against a complex medical background with inevitable psychological stress, all such patients should be considered at high risk for developing psychopathology.

Entities:  

Mesh:

Year:  1997        PMID: 9470875      PMCID: PMC1892332          DOI: 10.1136/hrt.78.6.581

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  15 in total

1.  Life at a price: the implantable defibrillator.

Authors:  R W Campbell
Journal:  Br Heart J       Date:  1990-09

2.  An analysis of the cost effectiveness of the implantable defibrillator.

Authors:  M Kuppermann; B R Luce; B McGovern; P J Podrid; J T Bigger; J N Ruskin
Journal:  Circulation       Date:  1990-01       Impact factor: 29.690

3.  A cognitive approach to panic.

Authors:  D M Clark
Journal:  Behav Res Ther       Date:  1986

4.  The coronary-care unit. An appraisal of its psychologic hazards.

Authors:  T P Hackett; N H Cassem; H A Wishnie
Journal:  N Engl J Med       Date:  1968-12-19       Impact factor: 91.245

Review 5.  Implantable cardioverter-defibrillators: the second decade.

Authors:  G P Fazio; E P Veltri
Journal:  Curr Opin Cardiol       Date:  1991-02       Impact factor: 2.161

6.  Cognitive therapy and pharmacotherapy. Singly and together in the treatment of depression.

Authors:  G E Murphy; A D Simons; R D Wetzel; P J Lustman
Journal:  Arch Gen Psychiatry       Date:  1984-01

7.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

8.  Distress or illness? A study of psychological symptoms after myocardial infarction.

Authors:  G G Lloyd; R H Cawley
Journal:  Br J Psychiatry       Date:  1983-02       Impact factor: 9.319

9.  Psychiatric assessment of patients with life-threatening cardiac arrhythmias.

Authors:  B Baker; S S Kazarian; P Dorian; C Lanphier
Journal:  Int J Psychiatry Med       Date:  1993       Impact factor: 1.210

10.  Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study.

Authors:  S Oehrberg; P E Christiansen; K Behnke; A L Borup; B Severin; J Soegaard; H Calberg; R Judge; J K Ohrstrom; P M Manniche
Journal:  Br J Psychiatry       Date:  1995-09       Impact factor: 9.319

View more
  8 in total

Review 1.  Exercise in cardiac rehabilitation.

Authors:  H J Bethell
Journal:  Br J Sports Med       Date:  1999-04       Impact factor: 13.800

2.  Psychological indices and phantom shocks in patients with ICD.

Authors:  Liza A Prudente; Juanita Reigle; Cheryl Bourguignon; David E Haines; John P DiMarco
Journal:  J Interv Card Electrophysiol       Date:  2006-08-04       Impact factor: 1.900

Review 3.  Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.

Authors:  Amir AbdelWahab; John Sapp
Journal:  Curr Cardiol Rep       Date:  2017-09-13       Impact factor: 2.931

4.  Panic disorders and agoraphobia: side effects of treatment with an implantable cardioverter/defibrillator.

Authors:  Frank Godemann; Christian Butter; Felix Lampe; Michael Linden; Michael Schlegl; Hans-Peter Schultheiss; Steffen Behrens
Journal:  Clin Cardiol       Date:  2004-06       Impact factor: 2.882

5.  Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: a randomised controlled trial.

Authors:  A Fitchet; P J Doherty; C Bundy; W Bell; A P Fitzpatrick; C J Garratt
Journal:  Heart       Date:  2003-02       Impact factor: 5.994

6.  Radiofrequency ablation for post infarction ventricular tachycardia.

Authors:  David O'Donnell; Voltaire Nadurata
Journal:  Indian Pacing Electrophysiol J       Date:  2004-04-01

Review 7.  Programming implantable cardioverter/defibrillators and outcomes.

Authors:  Fritz W Horlbeck; Joerg O Schwab
Journal:  F1000Prime Rep       Date:  2015-01-05

8.  Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.

Authors:  Pamela N Peterson; Robert T Greenlee; Alan S Go; David J Magid; Andrea Cassidy-Bushrow; Romel Garcia-Montilla; Karen A Glenn; Jerry H Gurwitz; Stephen C Hammill; John Hayes; Alan Kadish; Kristi Reynolds; Param Sharma; David H Smith; Paul D Varosy; Humberto Vidaillet; Chan X Zeng; Sharon-Lise T Normand; Frederick A Masoudi
Journal:  J Am Heart Assoc       Date:  2017-11-09       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.